a few people working at a table

Press Releases

Ladenburg Thalmann Acts as Exclusive Placement Agent for Vallon Pharmaceuticals, Inc. (VLON) in its $3.9 Million Registered Direct Offering

Transaction Information Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) announced that it has entered into...

Ladenburg Thalmann acted as Lead Bookrunner for Saratoga Investment Corp. on its $87.5 million offering of Unsecured Notes

Transaction Information New York, NY - Saratoga Investment Corp. (NYSE:SAR) (the "Company") announced that it...

Ladenburg Thalmann Acts as Co-Lead Manager for SCYNEXIS, Inc. (SCYX) in its $45 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants

Transaction Information SCYNEXIS, Inc. (Nasdaq: SCYX) announced the closing of its previously announced...

Ladenburg Thalmann Acts as Sole Book-Running Manager for Ra Medical Systems, Inc. (RMED) in its $12.1 Million Follow-On Offering

Transaction Information Ra Medical Systems, Inc. (NYSE American: RMED) announced the closing of an underwritten...

Ladenburg Thalmann Acts as Exclusive Placement Agent for NovaBay Pharmaceuticals (NBY) in its $15.0 Million Private Placement

Transaction Information NovaBay Pharmaceuticals, Inc. (NBY) announced it has entered into a Securities Purchase...

Ladenburg Thalmann Acts as Lead Manager for Evaxion Biotech in its $27.6 Million Follow-On Offering

Transaction Information Evaxion Biotech A/S (NASDAQ: EVAX), announced the closing of its follow-on public...

Ladenburg Thalmann Acts as Sole Book-Running Manager for Helius Medical Technologies, Inc. (HSDT) in its $11.1 Million Follow-On Offering

Transaction Information Helius Medical Technologies, Inc. (Nasdaq: HSDT) (TSX: HSM) announced underwritten...

Ladenburg Thalmann Acts as Sole Book-Running Manager for Nuwellis, Inc. (NUWE) in its $10.0 Million Follow-On Offering

Transaction Information Nuwellis, Inc. (NASDAQ: NUWE), announced the closing of its previously announced...

Ladenburg Thalmann Acts as Exclusive Placement Agent for Hancock Jaffe Laboratories (HJLI) in its $20 Million Registered Direct Offering Priced At-the-Market

Transaction Information Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI) announced it has entered into a...

  • 1
  • ...
  • 8
  • ...
  • 36